JP2021500400A5 - - Google Patents
Info
- Publication number
- JP2021500400A5 JP2021500400A5 JP2020542534A JP2020542534A JP2021500400A5 JP 2021500400 A5 JP2021500400 A5 JP 2021500400A5 JP 2020542534 A JP2020542534 A JP 2020542534A JP 2020542534 A JP2020542534 A JP 2020542534A JP 2021500400 A5 JP2021500400 A5 JP 2021500400A5
- Authority
- JP
- Japan
- Prior art keywords
- ring portion
- compound
- antiviral
- administering
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762573933P | 2017-10-18 | 2017-10-18 | |
| US62/573,933 | 2017-10-18 | ||
| PCT/US2018/056138 WO2019079339A1 (en) | 2017-10-18 | 2018-10-16 | COMPOSITIONS AND METHODS FOR BROAD SPECTRUM ANTIVIRAL THERAPY |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021500400A JP2021500400A (ja) | 2021-01-07 |
| JP2021500400A5 true JP2021500400A5 (enExample) | 2023-02-03 |
| JP7466907B2 JP7466907B2 (ja) | 2024-04-15 |
Family
ID=66173467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020542534A Active JP7466907B2 (ja) | 2017-10-18 | 2018-10-16 | 広域スペクトルの抗ウイルス治療のための組成物及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12213955B2 (enExample) |
| EP (1) | EP3697404B1 (enExample) |
| JP (1) | JP7466907B2 (enExample) |
| CN (1) | CN111886008B (enExample) |
| TW (1) | TWI860281B (enExample) |
| WO (1) | WO2019079339A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018089306A1 (en) | 2016-11-10 | 2018-05-17 | Oyagen, Inc. | Methods of treating and inhibiting ebola virus infection |
| WO2020258159A1 (en) * | 2019-06-27 | 2020-12-30 | Guangdong Oppo Mobile Telecommunications Corp., Ltd. | Method and device for indicating spatial relation information |
| US11738025B2 (en) | 2020-02-04 | 2023-08-29 | Oyagen, Inc. | Method for treating coronavirus infections |
| MX2022011111A (es) * | 2020-03-08 | 2023-03-02 | Humanigen Inc | Métodos para tratar infección de coronavirus y lesión pulmonar inducida por inflamación resultante. |
| US11628165B1 (en) * | 2020-03-25 | 2023-04-18 | Helen Feng | Method of boosting immune system against viral infection |
| ES2862462B2 (es) * | 2020-04-06 | 2023-04-27 | Servicio Andaluz De Salud | Compuestos para la profilaxis y/o el tratamiento del sindrome de dificultad respiratoria aguda |
| WO2021211738A1 (en) * | 2020-04-15 | 2021-10-21 | Sanford Burnham Prebys Medical Discovery Institute | Methods and compositions for antiviral treatment |
| WO2021226479A1 (en) * | 2020-05-07 | 2021-11-11 | The Regents Of The University Of California | Inhaled statins for treatment of viral respiratory diseases |
| CN116033894A (zh) * | 2020-05-22 | 2023-04-28 | 卡洛斯·阿尔贝托·里维罗斯 | 用于减少气道粘膜中的病毒复制的系统、方法和药物使用 |
| WO2021249240A1 (zh) * | 2020-06-11 | 2021-12-16 | 养生堂有限公司 | Palovarotene在抗hbv病毒治疗中的用途 |
| WO2022006446A1 (en) * | 2020-07-02 | 2022-01-06 | The Uab Research Foundation | Compositions and methods of treating conditions |
| CN112390731B (zh) * | 2020-11-16 | 2022-11-25 | 成都大学 | 一种具有多靶点的维甲酸类衍生物及其制备方法与应用 |
| US11998562B2 (en) | 2021-01-25 | 2024-06-04 | University Of South Florida | Ophthalmological formulations for the prevention of a coronavirus infection |
| JP2024504728A (ja) | 2021-01-26 | 2024-02-01 | サイトケアズ （シャンハイ） インコーポレイテッド | キメラ抗原受容体（ｃａｒ）構築物およびｃａｒ構築物を発現するｎｋ細胞 |
| US20220378727A1 (en) * | 2021-05-14 | 2022-12-01 | The University Of Hong Kong | Dry powder formulations of tamibarotene for pulmonary and intranasal delivery |
| CN116891497B (zh) * | 2022-04-02 | 2025-12-16 | 上海旭成医药科技有限公司 | 视黄酸受体激动剂、其制备方法、中间体、药物组合物和应用 |
| CN119013012A (zh) * | 2022-04-28 | 2024-11-22 | 国立大学法人东海国立大学机构 | 用于治疗伴随有舒张障碍的心力衰竭的药物组合物 |
| CN119454680B (zh) * | 2024-12-06 | 2025-06-17 | 华南农业大学 | 贝沙罗汀在制备抗prrsv或治疗猪蓝耳病的药物中的应用 |
| CN121177272A (zh) * | 2025-11-10 | 2025-12-23 | 北京市农林科学院 | 化合物am580在预防或治疗塞内卡病毒病中的用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7341717B2 (en) * | 2001-04-13 | 2008-03-11 | Gpc Biotech Ag | Therapeutic targets for treatment of HCV infections, methods of treating HCV infections and compounds useful therefor |
| CA2509955A1 (en) * | 2002-11-29 | 2004-06-17 | Gpc Biotech Ag | Formulations useful against hepatitis c virus infections |
| WO2005120479A1 (en) * | 2004-06-09 | 2005-12-22 | Gpc Biotech Ag | Use of selenium or a selenium salt and a retinoid acid or a retinoid in the treatment of viral hepatitis c |
| EP1886685A1 (en) | 2006-08-11 | 2008-02-13 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods, uses and compositions for modulating replication of hcv through the farnesoid x receptor (fxr) activation or inhibition |
| JP2010516702A (ja) | 2007-01-18 | 2010-05-20 | エヴォルヴァ エスアー | 置換１，３−ジオキサンのプロドラッグおよびそれらの使用 |
| CN104662036B (zh) | 2012-04-25 | 2018-11-09 | 华辉安健（北京）生物科技有限公司 | 乙肝肝炎病毒功能性受体的组成以及相关应用 |
| EP2922572A1 (en) * | 2012-11-23 | 2015-09-30 | AB Science | Use of small molecule inhibitors/activators in combination with (deoxy)nucleoside or (deoxy)nucleotide analogs for treatment of cancer and hematological malignancies or viral infections |
| MX2016010699A (es) * | 2014-02-18 | 2017-10-11 | Children's Hospital Los Angeles | Composiciones y metodos para tratar neutropenia. |
| WO2015138354A1 (en) | 2014-03-10 | 2015-09-17 | Cornell University | Combination therapy for head and neck cancer |
| WO2018054891A1 (en) * | 2016-09-20 | 2018-03-29 | Ruprecht-Karls-Universität | Compounds and combinations thereof for preventing and/or treating hbv and/or hdv infections |
-
2018
- 2018-10-16 WO PCT/US2018/056138 patent/WO2019079339A1/en not_active Ceased
- 2018-10-16 JP JP2020542534A patent/JP7466907B2/ja active Active
- 2018-10-16 CN CN201880080271.9A patent/CN111886008B/zh active Active
- 2018-10-16 EP EP18867413.9A patent/EP3697404B1/en active Active
- 2018-10-16 US US16/757,312 patent/US12213955B2/en active Active
- 2018-10-17 TW TW107136527A patent/TWI860281B/zh active